Modulation of Akt and ERK1/2 Pathways by Resveratrol in Chronic Myelogenous Leukemia (CML) Cells Results in the Downregulation of Hsp70. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.